Valuation : Amerise Biosciences Limited

Market Cap 38.98M 408K 350K 328K 300K 566K 567K 3.88M 1.52M 19.65M 1.53M 1.5M 65.02M P/E 2024
-29.8x
P/E 2025 1,056x
Enterprise Value 38.76M 406K 348K 326K 299K 563K 564K 3.86M 1.51M 19.53M 1.52M 1.49M 64.65M EV / Sales 2024
121x
EV / Sales 2025 31.9x
Free-Float
64.18%
Yield 2024 *
-
Yield 2025 -
08-04 Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-05 Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-02 Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02-02 Amerise Biosciences appoints Albert Hines as CFO RE
02-02 Amerise Biosciences Limited Announces Chief Financial Officer Changes, Effective February 2, 2026 CI
02-02 Amerise Biosciences Limited Announces Board Changes, Effective February 2, 2026 CI
11-05 Amerise Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
24/09/25 Amerise Biosciences Limited Appoints Kelash Bunkar as Independent Director, Effective 23 September 2025 CI
24/07/25 Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
19/05/25 Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025 CI
03/02/25 Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
03/02/25 Amerise Biosciences Limited Announces Resignation of Niraj Vaghela as Independent Director CI
28/01/25 Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors CI
1 day+5.00%
1 week-1.18%
Current month-16.83%
1 month-7.69%
3 months+18.31%
6 months+20.00%
Current year+37.70%
1 week 0.8
Extreme 0.8
0.85
1 month 0.8
Extreme 0.8
1.03
Current year 0.5
Extreme 0.5
1.03
1 year 0.5
Extreme 0.5
1.03
3 years 0.5
Extreme 0.5
1.45
5 years 0.5
Extreme 0.5
2.73
10 years 0.5
Extreme 0.5
2.73
Manager TitleAgeSince
Director of Finance/CFO - 02/02/2026
Compliance Officer - 15/04/2026
Director TitleAgeSince
Director/Board Member 57 24/06/2019
Director/Board Member 29 23/07/2022
Director/Board Member - 02/02/2026
Change 5-day change 1-year change 3-year change Capi.($)
+5.00%-1.18%+20.00%+33.33% 554K
-2.77%+2.42% - - 825M
+0.20%0.00% - - 645M
-4.82%-15.19%+250.30%-76.13% 630M
+0.37%+0.56% - - 601M
0.00%-0.39% - - 600M
-0.24%-0.24%+2.22% - 594M
+0.35%-1.03% - - 567M
+0.09%+0.38% - - 509M
Average -0.20%-1.04%+90.84%-21.40% 552.43M
Weighted average by Cap. -0.98%-0.34%+129.88%-76.03%

Financials

2024 2025
Net sales 359K 3.76K 3.23K 3.02K 2.77K 5.21K 5.23K 35.77K 13.98K 181K 14.11K 13.81K 599K 1.88M 19.68K 16.9K 15.82K 14.49K 27.29K 27.37K 187K 73.23K 948K 73.9K 72.31K 3.14M
Net income -1.46M -15.3K -13.13K -12.29K -11.26K -21.21K -21.27K -146K -56.91K -736K -57.43K -56.19K -2.44M 57K 596.81 512.3 479.63 439.19 827.34 829.69 5.68K 2.22K 28.73K 2.24K 2.19K 95.08K
Net Debt -211K -2.21K -1.9K -1.78K -1.63K -3.06K -3.07K -21.02K -8.22K -106K -8.29K -8.12K -352K -222K -2.32K -2K -1.87K -1.71K -3.22K -3.23K -22.12K -8.65K -112K -8.73K -8.54K -370K
Logo Amerise Biosciences Limited
Amerise Biosciences Limited is an India-based company. The Company is not engaged in any activity. The Company did not generate any revenue.
Employees
-
Date Price Change Volume
27/08/26 ₹0.8400 +5.00% 75,743
26/08/26 ₹0.8000 -3.61% 186,388
25/08/26 ₹0.8300 -1.19% 25,922
24/08/26 ₹0.8400 +1.20% 17,875
21/08/26 ₹0.8300 -2.35% 22,702
  1. Stock Market
  2. Stocks
  3. 531681 Stock